Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|December 27, 2003
[A case of enteropathy-associated T-cell lymphoma presenting with recurrent hematochezia]Dong Hoon Yang, Seung-Jae Myung, Hye-Sook Chang, et al.
The American Journal of Surgical Pathology|November 5, 2021
Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell LymphomaJin Roh, Dok Hyun Yoon, Yoon Kyoung Lee, et al.
Frontiers in Oncology|December 17, 2020
Superiority of Epstein-Barr Virus DNA in the Plasma Over Whole Blood for Prognostication of Extranodal NK/T Cell LymphomaJoo Young Ha, Hyungwoo Cho, Heungsup Sung, et al.
Investigational New Drugs|August 27, 2013
A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomasSeok Jin Kim, Hye Jin Kang, Jin Seok Kim, et al.
Oncotarget|October 21, 2016
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab eraSeyoung Seo, Jung Yong Hong, Shinkyo Yoon, et al.
Cancer Research and Treatment|December 17, 2020
Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin LevelsHyung-Don Kim, Hyungwoo Cho, Shin Kim, et al.
Blood Advances|September 17, 2021
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutationsJiwon Koh, Insoon Jang, Seungchan Mun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 12, 2019
Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entitiesCharles Van Slambrouck, Jooryung Huh, Cheolwon Suh, et al.
Cancer Research and Treatment|September 4, 2019
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II TrialSeok Jin Kim, Dok Hyun Yoon, Jin Seok Kim, et al.
International Journal of Cancer|August 9, 2011
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapyHo-Young Yhim, Jin Seok Kim, Hye Jin Kang, et al.
Pageof 21